Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
The immunomodulatory agent, lenalidomide, is a structural analogue of thalidomide approved by the US Food and Drug Administration for the treatment of myelodysplastic syndrome (MDS) and multiple myeloma (MM). This agent is also currently under active investigation for the treatment of chronic lympho...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2012-01-01
|
| coleção: | Advances in Hematology |
| Acesso em linha: | http://dx.doi.org/10.1155/2012/513702 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|